Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Evotec wins grant to advance H3 receptor antagonist

May 4, 2010 Research and Development CNS, Evotec, MS

Evotec is to receive funding of up to 1.5 million euros from a German government fund to advance its H3 …
News
Frazier

Merck separates president role, appoints Kenneth Frazier

April 30, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing

Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …
Appointment

Victoza claims head-to-head victory over Januvia

April 29, 2010 Research and Development, Sales and Marketing Novo, Novo Nordisk, Victoza

Novo Nordisk says its diabetes treatment showed “significant” benefits over Merck’s rival Januvia in a head-to-head trial. Results published in …
News

US pharma execs join Algeta board

April 29, 2010 Research and Development Algeta, appointment, research and development

Oslo-based oncology company Algeta has added Judith Hemberger and Kapil Dhingra to its board of directors. Judith Hemberger has more …
Appointment

RNA Interference using nanoparticles hits target in human patients

April 29, 2010 Research and Development SiRNA, nanoparticles, rnai

US researchers have shown that a targeted nanoparticle can penetrate cancer cells in order to deliver small interfering RNAs (siRNAs), …
News

Charles River to buy WuXi for $1.6bn

April 27, 2010 Research and Development Charles River, Charles River Laboratories, WuXi, contract research

Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …
News

Recovery signs, but outsourcing gets more competitive

April 26, 2010 Manufacturing and Production, Research and Development Interphex, contract manufacturing, contract research, contract research organisation

The first green shoots of  recovery in the global economy – assuming of course they are not going to be …
News

Elan looks again at hiving off drug delivery unit EDT

April 22, 2010 Research and Development, Sales and Marketing Elan

Irish drugmaker Elan says it is once again considering spinning out its drug delivery division, Elan Drug Technology, after abandoning …
News
BayerJogReinhardt

Bayer lures Novartis’ Reinhardt for top healthcare post

April 22, 2010 Research and Development, Sales and Marketing Bayer, appointment, research and development, sales and marketing

German pharma company Bayer has ended its search for someone to replace healthcare chief executive Arthur Higgins, appointing Dr Jörg …
Appointment

Astellas eyes oncology growth

April 21, 2010 Research and Development, Sales and Marketing Astellas, Astellas Pharma Europe

Astellas Pharma Europe has set its sights on the oncology market, earmarking the therapy area as its latest “franchise focus” …
News

GSK’s Arzerra conditionally approved in Europe

April 20, 2010 Research and Development, Sales and Marketing Arzerra, GSK, leukaemia

GlaxoSmithKline’s orphan cancer treatment Arzerra has been given conditional marketing authorisation in the European Union. Arzerra (ofatumumab) can be used …
News

Oracle buys eClinical specialist Phase Forward for $685m

April 20, 2010 Research and Development Covance, Oracle, Phase Forward

Business software giant Oracle has taken a leap forward in the healthcare arena with a $685 million cash offer to …
News

Trial boost for Merck KGaA’s cladribine

April 19, 2010 Research and Development Cladribine, MS, Merck KGaA, Merck Serono

New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …
News

MedImmune: building a biologics future

April 19, 2010 Research and Development MedImmune, biologics

I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …
Feature

Action Pharma appoints new chief executive

April 19, 2010 Research and Development Action Pharma, appointment, research and development

Ingelise Saunders has joined Danish biotech Action Pharma as its new chief executive. She will be involved in seeking partners …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025